A Case of Isolated Lymphoblastic Relapse of the Central Nervous System in a Patient with Chronic Myelogenous Leukemia Treated with Imatinib
'
A Case of Isolated Lymphoblastic Relapse of the Central Nervous System in a Patient with Chronic Myelogenous Leukemia Treated with Imatinib' 의 주제별 논문영향력
| 주제 |
|
|
|---|---|---|
| 동일주제 총논문수 | 논문피인용 총횟수 | 주제별 논문영향력의 평균 |
| 7,576 | 0 |
0.0% |
주제별 논문영향력
' A Case of Isolated Lymphoblastic Relapse of the Central Nervous System in a Patient with Chronic Myelogenous Leukemia Treated with Imatinib' 의 참고문헌
-
Prognostic discrimination in “good-risk” chronic granulocytic leukemia
-
Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy
-
Isolated central nervous system relapse of chronic myeloid leukemia after allogenic hematopoietic stem cell transplantation
-
Isolated central nervous system relapse in patients with chronic myeloid leukemia on imatinib mesylate
-
Isolated central nervous system relapse in lymphoid blast crisis chronic myeloid leukemia and acute lymphoblastic leukemia in patients on imatinib therapy
-
Isolated central nervous system lymphoid blast crisis in chronic myeloid leukaemia in major molecular remission
-
Isolated central nervous system blast crisis in chronic myeloid leukemia
-
Isolated central nervous system blast crisis in chronic myeloid leukemia
-
Isolated blast crisis in CNS in a patient with chronic myelogenous leukemia maintaining major cytogenetic response after imatinib
-
Isolated CNS relapse of CML after bone marrow transplantation
-
Extramedullary blast crisis derived from 2 different clones in the central nervous system and neck during complete cytogenetic remission of chronic myelogenous leukemia treated with imatinib mesylate
-
Dasatinib maintenance therapy after allogeneic hematopoietic stem cell transplantation for an isolated central nervous system blast crisis in chronic myelogenous leukemia
-
Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels
-
Current issues in chronic myeloid leukemia: monitoring, resistance, and functional care
-
Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet
-
Central nervous system is a sanctuary site for chronic myelogenous leukaemia treated with imatinib mesylate
-
Central nervous system failure in patients with chronic myelogenous leukemia lymphoid blast crisis and Philadelphia chromosome positive acute lymphoblastic leukemia treated with imatinib (STI-571)
-
Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report
-
CNS blast crisis of chronic myelogenous leukemia in a patient with a major cytogenetic response in bone marrow associated with low levels of imatinib mesylate and its N-desmethylated metabolite in cerebral spinal fluid
-
A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group